BioArmix

Company Overview

Snapshot

Founded in February 2024 by Tzvi Zvirin, Gal Sason, Amos Nussinovitch, and Edouard Jurkevitch, BioArmix operates with 1–10 employees. The company has secured $23,000 across two funding rounds.

Business overview

BioArmix develops biological solutions for crop protection, focusing on combating bacterial plant pathogens to enhance sustainable agriculture and food security. The company utilizes naturally occurring, non-GMO predatory bacteria that specifically target harmful gram-negative bacterial pathogens affecting various crops. BioArmix employs a proprietary encapsulation technique to preserve the viability of these bacteria, delivering them in a stable, dry powder form at room temperature. The company operates within the Agriculture & Food Technologies sector, with a focus on Ag Tech, Genetics & Input, Climate Tech, Food & Land Use, and Sustainable Farming.

Strategic signal

This grant validates the company's innovative approach to biological crop protection and signals strong institutional support for its sustainable agricultural solutions, indicating potential for accelerated product development and market entry.

Company Intelligence Q&A

When was BioArmix founded?

BioArmix was founded in February 2024 by Tzvi Zvirin, Gal Sason, Amos Nussinovitch, and Edouard Jurkevitch.

What is BioArmix's primary focus?

BioArmix focuses on developing biological solutions to combat bacterial plant pathogens, promoting sustainable agriculture and enhanced food security through the use of naturally occurring, non-GMO predatory bacteria.

How does BioArmix ensure the stability of its biological solutions?

BioArmix employs a proprietary encapsulation technique to preserve the viability of its predatory bacteria, allowing them to be stored in a dry powder form that remains stable at room temperature.